MoneyWorks4Me

Coral Laboratories submits statement of deviation

04 Jul 2019 Evaluate

Coral Laboratories has informed about submission of Statement of Deviation or Variation under Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 for the Quarter ended 30th June, 2019. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1850.10
Dr. Reddys Labs. 1201.85
Cipla 1400.20
Lupin 2095.40
Zydus Lifesciences 1187.95
View more..